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Background: Epidemiological studies indicate that cadmium exposure through diet and smoking is as-
sociated with increased risk of cardiovascular disease. There are few data on the relationship between
cadmium and plaques, the hallmark of underlying atherosclerotic disease.
Objectives: To examine the association between exposure to cadmium and the prevalence and size of
atherosclerotic plaques in the carotid artery.
Methods: A population sample of 4639 Swedish middle-aged women and men was examined in 1991–
1994. Carotid plaque was determined by B-mode ultrasound. Cadmium in blood was analyzed by in-
ductively coupled plasma mass spectrometry.
Results: Comparing quartile 4 with quartile 1 of blood cadmium, the odds ratio (OR) for prevalence of any
plaque was 1.9 (95% conﬁdence interval 1.6–2.2) after adjustment for sex and, age; 1.4 (1.1–1.8) after
additional adjustment for smoking status; 1.4 (1.1–1.7) after the addition of education level and life style
factors; 1.3 (1.03–1.8) after additional adjustment for risk factors and predictors of cardiovascular disease.
No effect modiﬁcation by sex was found in the cadmium-related prevalence of plaques. Similarly, ORs for
the prevalence of small and large plaques were after full adjustment 1.4 (1.0–2.1) and 1.4 (0.9–2.0),
respectively. The subgroup of never smokers showed no association between cadmium and athero-
sclerotic plaques.
Conclusions: These results extend previous studies on cadmium exposure and clinical cardiovascular
events by adding data on the association between cadmium and underlying atherosclerosis in humans.
The role of smoking remains unclear. It may both cause residual confounding and be a source of pro-
atherogenic cadmium exposure.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cadmium is a non-essential, toxic metal that is widely dis-
tributed in the environment. It has been used in batteries, paints,
and plastic stabilizers, and is a common contaminant in fertilizers.
The impact of environmental contamination of cadmium is aInc. This is an open access article u
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@med.lu.se (G. Östling),
e@med.lu.se (Y. Borné),
d@med.lu.se (B. Hedblad).major concern (Nordberg et al., 2007; EFSA. European Food Safety
Authority, 2009; Agency for Toxic Substances and Disease Registry
(ATSDR), 2012). Grains, and leafy and root vegetables as well as
tobacco plants bio-concentrate cadmium, leading to exposure
through diet and smoking. Cadmium in tobacco smoke is effec-
tively absorbed in the lungs. Cadmium levels are higher in women
than men, mainly because of increased intestinal absorption of
dietary cadmium at low iron stores secondary to menstruation and
pregnancy. Whole blood and urine concentrations of cadmium
have long biological half-lives and are valid biomarkers of cumu-
lative exposure in the general population (Nordberg et al., 2007;
EFSA. European Food Safety Authority, 2009).
Cadmium is a very cytotoxic metal and results from experi-
mental studies indicate that cadmium exposure may causender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ramanyam et al., 1992; Almenara et al., 2013; Prozialeck et al.,
2008). Tentative causal mechanisms are disruption of endothelium
and increase in reactive oxygen species formation. In humans,
cadmium is enriched in arterial vessel walls (Abu–Hayyeh et al.,
2001). As summarized in a recent review, several epidemiological
studies, mostly from the US, have examined the associations be-
tween low to moderate exposure to cadmium and cardiovascular
disease (Tellez–Plaza et al., 2013). Exposure was measured as
cadmium concentrations in blood or urine. In the mentioned re-
view, a meta-analysis of twelve studies of good quality, cadmium
exposure was reported to increase the risk of cardiovascular dis-
ease by 36%. The pooled relative risks for cardiovascular disease in
men, women and never smokers were 1.29 (95% conﬁdence in-
terval 1.12–1.48), 1.20 (0.92–1.56) and 1.27 (0.97–1.67),
respectively.
Atherosclerotic plaque is the culprit lesion of atherosclerotic
disease. High resolution ultrasound technique makes it possible to
study the occurrence and size of such plaques in the carotid ar-
teries. Data are still lacking on the relationship between cadmium
exposure and development of atherosclerosis in humans. To our
knowledge, there is only one published study that has examined
associations between cadmium exposure and plaque status. In that
study, of a cohort of 64-year-old Swedish women, blood and ur-
inary cadmium levels were associated with carotid plaques in
terms of occurrence, size, and growth, after 6 years of follow-up
(Fagerberg et al., 2012). The results were not conclusive in the
subgroup of never smokers and there are no data available for
men. Accordingly, the present study was undertaken with the aim
to examine if cadmium exposure is associated with the prevalence
and size of atherosclerotic plaques, not only in women but also in
men, and if this association can be found in never smoking
subjects.2. Material and methods
2.1. Study population
As previously described in detail, all men and women living in
the city of Malmö in Sweden, born between 1923 and 1945, were
invited between 1991 and 1996 to participate in the Malmö Diet
and Cancer Study (MDCS) (Berglund et al., 1993). The aim was to
investigate the relation between dietary factors and cancer. Be-
tween 1991 and 1994 a random sample of the MDC cohort, the
MDC cardiovascular cohort, was selected for a substudy with the
aim of studying the epidemiology of carotid artery disease (Rosvall
et al., 2000). A total of 6103 subjects underwent an ultrasound
examination at the ﬁrst visit in the study and where rescheduled
for fasting blood sampling (with a median timelag of 7 months)
under standardized conditions (Rosvall et al., 2005).
Inclusion criteria in the present study were available data on
ultrasound-assessed plaque status in the carotid artery, blood
cadmium concentration, and smoking status. Data were missing in
254, 1155, and 315 subjects, respectively, and 4639 subjects were
included in the present study. The mean age of subjects in the total
subcohort and subjects participating in the present study was al-
most identical (57.5 and 57.4 years, respectively). Women con-
stituted 57.9% and 59.6%, respectively, of the study population.
Carotid plaques were found in 34.6% of those in the total sub-
cohort and in 35.4% of the subjects in the present study.
2.2. Cardiovascular risk factors
The subjects completed established questionnaires concerning
life style, socioeconomic status, including occupation, health, andmedication (Rosvall et al., 2000). The subjects were categorized
into never, ex-, and current smokers. The last category also in-
cluded those who smoked occasionally. Pack-years of smoking
were calculated as the product of the years of smoking and the
number of daily smoked cigarettes, divided by 20. Data on pack-
years were available for 1160 current smokers, 789 ex-smokers,
and all non-smokers (n¼1,851), who were given the value of zero
(in total n¼3,800). The daily alcohol intake was calculated. Leisure
time physical activity was a composite measure of 18 different
leisure time activities during the preceding year. A summary score
of all physical activities was obtained by using intensity factors for
each activity, combined with information on time spent on the
activity (Li et al., 2009). Low physical activity was deﬁned as the
lowest quartile of the summary score. Educational level was
classiﬁed into three categories: “Primary education” – o9 years of
education; “some secondary education” – 9 and up to 11 years of
education; and “completed secondary education” – 12 years or
more of education. Anti-hypertensive and lipid-lowering treat-
ment, postmenopausal status, and hormone replacement therapy
were assessed by questionnaire. Height, waist circumference, and
body mass were recorded and body mass index (BMI) was calcu-
lated. Systolic and diastolic blood pressure was measured after
supine rest for 10 min.
Overnight fasting blood samples were drawn for determination
of high density lipoprotein (HDL) cholesterol, low density lipo-
protein (LDL) cholesterol, triglycerides, hemoglobin A1c (HbA1c),
and whole blood glucose according to standard procedures at the
Department of Clinical Chemistry, Malmö University Hospital.
High sensitivity C-reactive protein (hsCRP) (mg/L) was measured
from frozen samples (80 °C) and analyzed using the Tina-quant
CRP latex high sensitivity assay (Roche Diagnostics, Basel, Swit-
zerland) on an ADVIA 1650 Chemistry System (Bayer Healthcare,
Tarrytown, NY, US). Subjects were classiﬁed as having diabetes
mellitus if they reported the diagnosis in the questionnaire, used
anti-diabetic medication, or had a fasting venous whole blood
glucose Z6.1 mmol/L.
2.3. Ultrasound examination
As previously reported, subjects underwent B-mode ultra-
sonography (Acuson128 CT system, Siemens, Mountain View, Ca,
USA) of the right carotid artery, according to a standardized pro-
tocol, performed by trained, certiﬁed sonographers (Rosvall et al.,
2000). In short, the bifurcation area of the right common carotid
artery was scanned within a pre-deﬁned “window” comprising
3 cm of the distal common carotid artery, the bifurcation, and 1 cm
of the internal and external carotid artery, respectively, for the
occurrence of plaques (deﬁned as a focal thickening of the intima-
media complex 41.2 mm and with an area Z10 mm2). The de-
gree of stenosis by visually judging to what extent the plaque
protruded into the lumen was possible to assess in 1152 subjects.
Methods of quality control were used, as described previously
(Rosvall et al., 2000).
2.4. Blood cadmium concentrations
In whole blood, cadmium is located in red blood cells with only
marginal levels in plasma (Nordberg et al., 2007). Cadmium con-
centrations were analyzed in erythrocytes which had been kept
frozen in 80 °C since the baseline examination. These con-
centrations were adjusted for hematocrit to obtain the calculated
cadmium concentrations in blood.
Cadmium in erythrocytes was analyzed by inductively coupled
plasma mass spectrometry with an octopole reaction system
(Agilent 7700x ICP-MS; Agilent Technologies, Santa Clara, Ca,
USA). The reaction systemwas operated in the helium collision cell
B. Fagerberg et al. / Environmental Research 136 (2015) 67–74 69mode to eliminate interference from isobaric polyatomic species
via kinetic energy discrimination. Samples were introduced using
a peristaltic pump and nebulization was carried out with a Mira-
Mist nebulizer (Agilent Technologies, Santa Clara, Ca, USA). The
spray chamber used was a Scott-type double pass spray chamber
operated at 2 °C. A standard quartz torch with 2.5 mm internal
diameter (ID) injector was used. The instrument was equipped
with an Agilent I-AS integrated autosampler (Agilent Technologies,
Santa Clara, Ca, USA).
All samples were diluted 20 times with a basic diluent con-
taining 1-butanol (2% w/v), ethylenediamine tetraacetic acid
(EDTA) (0.05% w/v), Triton X-100 (0.05% w/v), and ammonium
hydroxide (1% w/v). Indiumwas used as internal standard and was
added from an internal standard mix (Agilent Technologies) con-
taining 10 mg/L, to give a ﬁnal concentration of 25 mg/L.
The imprecision was 9.6%, calculated as the coefﬁcient of var-
iation for 50 duplicate samples (mean 0.43 mg/L). The limit of de-
tection (LOD), calculated as three times the standard deviation of
the blank, was 0.02 mg/L. None of the samples were below the LOD.
All samples were analyzed in three different rounds with external
quality control (QC) samples included. Two QC samples were used
(Seronorm™ Trace Elements Whole Blood L-1, Lot no. 1103128, and
Seronorm™ Trace Elements Whole Blood L-2, Lot No.1103129; Sero
AS, Billingstad, Norway). The results from all rounds vs. re-
commended limits were 0.3470.02 mg /L (N¼70) vs. 0.32–
0.40 mg/L, and 5.770.18 mg/L (N¼70) vs. 5.4–6.2 mg/L. The results
for the three rounds were similar. Furthermore, a comparison in-
cluding 20 erythrocyte samples (range 0.2–0.96 mg/L) was made
with another laboratory (Occupational and Environmental Medi-
cine, Lund, Sweden). The results showed good agreement, with a
Pearson's correlation coefﬁcient of 0.99 and a slope of 1.04 (stan-
dard error (SE) 0.04).
2.5. Statistical analyses
PASW 18.0 (SPSS Inc., Chicago, IL, USA) was used for the sta-
tistical analyses. The prevalence of any plaque was the primary
response variable followed by the prevalence of small and large
plaques, respectively. Results are presented as means (standard
deviation (SD) for continuous variables, and as percentage for ca-
tegorical variables. Blood cadmium concentrations and other
skewed variables are presented as geometric mean (5th–95th
percentiles). Differences between groups were analyzed with
analysis of variance (ANOVA), t-test, and trend test after log
transformation of skewed variables. Differences in proportions
were analyzed with chi-square test. Logistic regression was used to
examine the odds ratios (ORs) for plaque occurrence by quartiles
of blood cadmium levels. Since we found no effect modiﬁcation by
sex in the cadmium-related prevalence of plaques, the primary
analysis was performed in the total sample, including both sexes.
To adjust for the inﬂuence of the potential confounders in the
analyses, we ﬁrst adjusted for age and sex and then used three
models. Model 1 included also smoking status. Model 2 ad-
ditionally adjusted for o9 years of schooling, lowest quartile of
physical activity score, and alcohol intake. Model 3 additionally
adjusted for waist circumference, systolic blood pressure, LDL and
HDL cholesterol, triglycerides, HbA1c, hsCRP, antihypertensive
treatment, lipid-lowering treatment, diabetes, postmenopausal
status, hormone replacement therapy.
In separate analyses, pack-years were substituted for smoking
status. Subgroup analyses were performed by evaluating differ-
ential associations by sex and smoking subgroups. The odds ratio
for plaque occurrence was also estimated as a smooth function of
blood cadmium (adjusted for sex, smoking and age), using the
procedure gam in the ‘mgcv’ package in R version 3.0.2, where the
smooth term was represented using a penalized regression spline(with 4.262 edf). Two-sided po0.05 was considered statistically
signiﬁcant.3. Results
The geometric mean blood cadmium concentration was
0.31 μg/L (0.32 μg/L (5th–95th percentiles 0.11–1.61) for women
and 0.29 μg/L (5th–95th percentiles 0.09–1.60) for men). Two
subjects had occupations with potential exposure for cadmium,
but blood cadmium levels were not high (data not shown). As
shown in Table 1, blood cadmium levels were positively associated
with female sex, age, serum triglycerides, HbA1c, hsCRP, and
smoking burden in terms of smoking status and pack-years. There
were negative associations with BMI, waist circumference, edu-
cational level, and physical activity.
3.1. Prevalence of plaques
The prevalence of atherosclerotic plaques in each of the 1st–4th
cadmium quartiles was 31.5% (n¼365), 31.3% (n¼363), 34.3%
(n¼398), and 44.3% (n¼514), respectively (po0.0001 for both
chi-square test and trend analysis). Fig. 1 demonstrates the esti-
mated risk of plaque as a smooth function of blood cadmium after
adjustment for sex, age and smoking status and supports the
use of quartiles of cadmium in the further analyses. As shown in
Table 2, comparing quartile 4 with quartile 1 of blood cadmium
levels, the OR for plaque prevalence was 1.9 (95% CI 1.6–2.2) after
adjustment for sex and age, 1.4 (1.1–1.8) after additional adjust-
ment for smoking status, 1.4 (1.1–1.7) after further adjustment for
educational level, life style factors and ﬁnally 1.3 (1.03–1.8) after
additional adjustment for all potential clinical confounders. The
results remained principally unchanged in Model 1 and 2 when
the analyses were performed in the subjects with complete data in
Model 3 (data not shown). In additional analyses, pack-years were
substituted for smoking status, showing similar results (ORs for
plaque prevalence after adjustment for age and sex, Model 1, 2 and
3, were 1.9 (1.6–2.2), 1.6 (1.3–1.9), 1.5 (1.2–1.9), and 1.6 (1.3–2.1),
respectively).
3.2. Plaque size
The degree of luminal stenosis was possible to determine in
551 women and 601 men with plaques. Small plaques were de-
ﬁned as a degree of stenosis below the median (o20% stenosis)
and large plaques as above the median (stenosis 20–80%). As
shown in Fig. 2, the prevalences of these small and large plaques
increased by blood cadmium quartiles in both sexes. Logistic re-
gression analyses showed that when cadmium quartiles 4 and
1 were compared, the OR for occurrence of small plaques was 2.0
(1.5–2.6) after adjustment for age and sex, and 1.5 (1.04–2.1) after
adjustment for smoking, educational level and life style factors
and 1.4 (1.0–2.1) after full adjustment (Table 3). For large plaques,
the corresponding ORs were 2.4 (1.9–3.2), 1.5 (1.1–2.1), and 1.4
(0.9–2.0) (Table 3). In additional analyses, when pack-years were
substituted for smoking status, the OR was 1.8 (1.3–2.5) for small
plaques and 1.7 (1.2–2.3) for large plaques, after full adjustment
according to Model 3.
3.3. Subgroup analyses
In the subgroup analyses, the interaction term for sex and
cadmium concentrations was not statistically signiﬁcant with re-
gard to plaque prevalence in the logistic regressions (p¼0.15 in
Model 3). The distributions of small and large plaques by cadmium
quartiles for each sex are shown in Fig. 2. Fig. 3 presents the
Table 1
Associations between factors related to cardiovascular disease and blood cadmium concentrations in middle aged women (n¼2,764) and men (n¼1,875).
Variable Quartiles of blood cadmium P for trend P for quartile 4 vs.
quartile 1
1 (n¼1,159) 2 (n¼1,160) 3 (n¼1,160) 4 (n¼1,160)
Blood cadmium, μg/L (GMa, minimum–maximum) 0.12 (0.03–0.17) 0.21
(0.17– o0.26)
0.34
(0.26– o0.50)
1.04 (0.50–5.10) – –
Women, n (%) 577 (49.8) 728 (62.8) 768 (66.2) 691 (59.6) o0.001 o0.001
Age, (mean7SD), yrs 56.975.9 57.876.0 58.275.8 56.875.9 o0.001 0.73
BMI, (mean7SD), kg/m2 25.973.9 25.773.7 25.773.8 25.073.9 o0.001 o0.001
Waist, cm (GMa [5th–95th percentiles]) 84.1 [66–106] 81.9 [65–104] 81.5 [65–104] 81.5 [65–104] o0.001 o0.001
Low educational level (o9 years of schooling), n (%) 477 (41.2) 502 (43.4) 535 (48.3) 606 (52.3) o0.001 o0.001
Low physical activity, n (%) 255 (22.2) 275 (23.9) 285 (24.8) 335 (29.1) 0.001 o0.001
Postmenopausal status, n (%) (n¼576/726/765/689)b 429 (74.5) 536 (73.8) 569 (74.4) 506 (73.4) 0.75 0.68
Hormonal replacement therapy, n (%) 107 (21.8) 125 (19.5) 136 (19.7) 118 (18.8) 0.26 0.20
(n¼490/642/690/629)b
Smoking status, n (%) o0.001 o0.001
Never smoker 726 (62.6) 596 (51.4) 459 (39.6) 70 (6.0)
Ex-smoker 390 (33.6) 499 (43.0) 526 (45.3) 146 (12.6)
Current smoker 43 (3.7) 65 (5.6) 175 (15.1) 944 (81.4)
Pack-years of smoking (mean7SD)
(n¼961/903/873/1,063)b
2.8 (10.2) 4.9 (12.6) 8.2 (18.0) 25.5 (20.5) o0.001 o0.001
Lipid lowering treatment, n (%) 26 (2.2) 22 (1.9) 36 (3.1) 28 (2.4) 0.39 0.79
Treatment for hypertension, n (%) 165 (14.2) 200 (17.2) 213 (18.4) 168 (14.5) 0.70 0.87
Diabetes mellitus, n (%) 112 (9.7) 82 (7.1) 78 (6.7) 87 (7.3) 0.052 0.063
Alcohol intake, (mean7SD), g/day 10711 10712 10711 11714 0.16 0.11
Systolic blood pressure, (mean7SD), mmHg 141718 141719 142719 140719 0.73 0.43
Diastolic blood pressure, (mean7SD), mmHg 8779 8779 8779 8679 0.33 0.25
LDLc cholesterol, (mean7SD), mmol/L
(n¼1,122/1,132/1,129/1,130)b
4.1571.00 4.1970.96 4.1270.96 4.2271.02 0.32 0.13
HDLd cholesterol, (mean7SD), mmol/L 1.3570.36 1.4370.38 1.4370.38 1.3570.37 1.00 0.84.
Serum triglycerides, mmol/L
(GMa [5th–95th percentiles])
1.22 [0.60–2.98] 1.17 [0.59–2.59] 1.15 [0.58–2.55] 1.27 [0.64–2.88] 0.051 0.025
HbA1ce, mmol/mol (GM [5th–95th percentiles]) 40 [32–51] 40 [32–48] 40 [32–48] 42 [34–50] o0.001 o0.001
hsCRPf, mg/L (GM [5th–95th percentiles]) 1.22 [0.2–6.94] 1.23 [0.2–7.1] 1.37 [0.3–7.83] 1.76 [0.3–10.6] o0.001 o0.001
a GM¼geometric mean.
b n in each quartile.
c LDL¼ low density lipoprotein.
d HDL¼high density lipoprotein.
e HbA1c¼hemoglobin A1c.
f hsCRP¼high sensitivity C-reactive protein.
Fig. 1. Estimated blood cadmium concentration–response. curve and
95% conﬁdence interval for plaque occurrence (the model is adjusted for sex,
smoking and age). Individual values of blood cadmium are indicated on
the X-axis. and the arrows show the geometric means of blood cadmium in quartile
1–4.
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centrations in each sex. The OR for the prevalence of carotid pla-
ques in quartile 4 compared to quartile 1 was, after full adjustment
(Model 3), 1.5 (1.02–2.2) in women (Supplementary Table 1).
When smoking status was replaced by pack-years of smoking, the
corresponding OR was 1.6 (1.1–2.3). In men, the corresponding ORs
were 1.2 (0.8–1.8) (Supplementary Table 2) and 1.6 (1.1–2.2) if
pack-years were used as measure of cumulative smoking.
A statistically signiﬁcant interaction termwas found for current
smoking and blood cadmium regarding plaque prevalence (OR 1.9
(95% CI 1.04–3.3), Model 3). As shown in Fig. 3 and Supplementary
Fig. 1, very few non-smokers had high blood cadmium levels, and
very few current smokers had low cadmium levels. To examine the
association between blood cadmium and plaque prevalence by
smoking status, speciﬁc tertiles of blood cadmium were therefore
calculated separately for never smokers, ex-smokers, and current
smokers. As shown in Supplementary Fig. 1, blood cadmium
concentrations in the second and third tertiles in current smokers
were high and did not even overlap with the concentrations in the
never and ex-smoking groups. In never smoking subjects, tertile
3 and tertile 1 of blood cadmium levels were compared and the OR
for plaque prevalence was 0.8 (95% CI 0.6–1.1) after adjustment for
sex and age, 0.8 (0.6–1.1), and 0.8 (0.6–1.1) after adjustments ac-
cording to Model 2 and 3, respectively (Supplementary Table 3). In
ex-smokers, the corresponding ORs were 1.4 (1.1–1.8), 1.4 (1.05–
1.8), and 1.3 (1.0–1.8) and among current smokers, 2.0 (1.5–2.6), 1.9
Table 2
Odds ratios for prevalence of any atherosclerotic plaque in the right carotid artery by quartiles of blood cadmium concentrations (n¼4,639).
Model Odds ratios (95% conﬁdence intervals) by quartiles of blood cadmium concentrations [n in each quartile] P for trend P for quartile
4-1
1 2 3 4
Adjusted for sex and
age
1 [1159] 1.0 (0.8–1.1) [1160] 1.1 (0.9–1.3) [1160] 1.9 (1.6–2.2) [1160] o0.001 o0.001
Model 1a 1 [1159] 0.9 (0.8–1.1) [1160] 1.0 (0.8–1.2) [1160] 1.4 (1.1–1.8) [1160] 0.003 0.007
Model 2b 1 [1149] 0.9 (0.7–1.1) [1142] 1.0 (0.8–1.2) [1140] 1.4 (1.1–1.7) [1143] 0.005 0.016
Model 3c 1 [990] 0.9 (0.8–1.1) [992] 0.9 (0.8–1.2) [996] 1.3 (1.03–1.8) [990] 0.029 0.032
a Model 1: Sex, age, smoking status (never smoker, ex-smoker, current smoker).
b Model 2: Additionally adjusted for o9 years of schooling, lowest quartile of physical activity score, and alcohol intake.
c Model 3. Additionally adjusted for waist circumference, systolic blood pressure, low density lipoprotein and high density lipoprotein cholesterol, triglycerides, HbA1c,
C-reactive protein, antihypertensive treatment, lipid-lowering treatment, diabetes, postmenopausal status, hormone replacement therapy.
Fig. 2. Unadjusted prevalence of small and large atherosclerotic plaques with
o20% lumen stenosis (white bars) and 20–80% lumen stenosis (black bars)
(n¼2,446[women]/1678[men]). There were 286 (11.7%) small and 309 (12.6%) large
plaques among women. For men, the corresponding numbers were 265 (15.8%) and
292 (17.4%), respectively.
B. Fagerberg et al. / Environmental Research 136 (2015) 67–74 71(1.4–2.5), and 1.7 (1.2–2.4) (Supplementary Tables 4 and 5). In a
further analysis, pack-years were added to Model 3 in ex-smokers
(n¼679) and current smokers (n¼995) and the comparison be-
tween tertiles 1 and 3 in ex-smokers showed an OR of 1.2 (0.7–1.8)
for plaque prevalence; in current smokers, the corresponding
ﬁgure was 1.7 (1.1–2.4).4. Discussion
In the present cross-sectional study of a large population-based
sample, we observed that blood cadmium concentrations were
associated with atherosclerotic plaques in the carotid artery, interms of both prevalence and size. The concentration of cadmium
in blood was used as an established measure of cadmium exposure
and the observed level corresponded well to that in a previously
published study from Sweden (Fagerberg et al., 2012). The plaque
status was assessed with high resolution ultrasound technique
(Rosvall et al., 2000). In the present study, statistical adjustment
was made for a wide array of risk factors for cardiovascular dis-
ease, ranging from socioeconomic and life style factors to tradi-
tional and novel cardiovascular risk factors.
Our results are in line with ﬁndings in a previous, smaller study
of 64-year-old Swedish women, in whom blood as well as urine
cadmium concentrations were associated with carotid plaques in
terms of prevalence and size (Fagerberg et al., 2012). In that study,
cadmium exposure was related to growth of plaques during fol-
low-up. Hence, the result from the present study supports the
hypothesis that cadmium exposure is associated with the occur-
rence and size of carotid plaques. Not only the prevalence of pla-
ques, but also the size of carotid plaques has been shown to im-
prove prediction of future cardiovascular disease in addition to
cardiovascular risk factors (Rosvall et al., 2005; Wyman et al.,
2006; Spence et al., 2002). In a clinical context this means that the
cadmium exposure corresponding to the highest 25% in the pre-
sent population sample is associated with an odds ratio of 1.3 for
carotid plaque, and that those with plaques have an 80% increase
in relative risk for future coronary events, on top of the risk as-
sociated with usual cardiovascular risk factors (Rosvall et al.,
2005). In addition, comparing large carotid plaques with no, or
very small plaques is associated with a tree-fold increase in the
risk of future cardiovascular disease after adjustment for tradi-
tional cardiovascular risk factors (Spence et al., 2002).
We also estimated the risk of plaque as a smooth function of
blood cadmium, adjusted for sex, smoking and age. The result
showed that in the range that encompassed the geometric means
of the quartiles of blood cadmium (0.12–1.04 μg/L) there was a
fairly linear association with plaque prevalence. Hence, we ﬁnd it
justiﬁable to use blood cadmium levels divided into quartiles in
the statistical analyses.
In the present study, an interaction analysis did not reveal any
effect modiﬁcation by sex in the cadmium-related prevalence of
plaques. Still, in the subgroup analysis of the association between
blood cadmium levels and plaque prevalence, statistical sig-
niﬁcance was not attained for men in the fully adjusted model,
except when smoking status was substituted by pack-years.
Previous epidemiological studies more often report an asso-
ciation between cadmium exposure and cardiovascular disease in
men than in women (Tellez–Plaza et al., 2013). It is important to
keep in mind that the occurrence of clinical atherosclerotic dis-
ease, such as symptomatic carotid stenosis, is dependent on the
process of a stable plaque transforming into an unstable plaque
Table 3
Odds ratios for prevalences of smalla (o20% luminal stenosis) and largea (20–80% luminal stenosis) atherosclerotic plaques in the right carotid artery by quartiles of blood
cadmium concentrations.
Model
(n in each quartile)
Odds ratios (95% conﬁdence intervals) by quartiles of blood cadmium concentrations
[n in each quartile]
P for trend P for quartile 4 vs.
quartile 1
1 2 3 4
Adjusted for sex, age
Small plaques 1 [905] 1.0 (0.7–1.3) [913] 1.2 (0.9–1.6) [893] 2.0 (1.5–2.6) [812] o0.001 o0.001
Large plaques 1 [908] 1.0 (0.7–1.3) [915] 1.2 (0.9–1.5) [893] 2.4 (1.9–3.2) [857] o0.001 o0.001
Model 1b
Small plaques 1 [905] 0.9 (0.7–1.3) [913] 1.1 (0.8–1.5) [893] 1.5 (1.04–2.1) [812] 0.07 0.028
Large plaques 1 [908] 0.9 (0.7–1.2) [915] 1.0 (0.7–1.3) [893] 1.6 (1.2–2.3) [857] 0.003 0.005
Model 2c
Small plaques 1 [899] 0.9 (0.7–1.3) [902] 1.1 (0.8–1.5) [877] 1.5 (1.04–2.1) [801] 0.07 0.031
Large plaques 1 [900] 0.9 (0.7–1.2) [906] 1.0 (0.7–1.3) [877] 1.5 (1.1–2.1) [845] 0.018 0.023
Model 3d
Small plaques 1 [793] 1.0 (0.7–1.3) [789] 1.1 (0.8–1.3) [789] 1.4 (1.0–2.1) [702] 0.23 0.09
Large plaques 1 [796] 0.9 (0.7–1.2) [789] 0.9 (0.7–1.2) [782] 1.4 (0.9–2.0) [748] 0.08 0.14
a There were 551 subjects with small plaques, 601 subjects with large plaques and 2972 subjects with no plaques or stenoses.
b Model 1: Sex, age, smoking status (never smoker, ex-smoker, current smoker).
c Model 2: Additionally adjusted for o9 years of schooling, lowest quartile of physical activity score, and alcohol intake.
d Model 3: Additionally adjusted for waist circumference, systolic blood pressure, low density lipoprotein and high density lipoprotein cholesterol, triglycerides, HbA1c,
C-reactive protein, antihypertensive treatment, lipid-lowering treatment, diabetes, postmenopausal status, hormone replacement therapy.
Fig. 3. Percentage of subjects according to smoking status in each quartile of blood
cadmium in women (upper panel) and men (lower panel).
B. Fagerberg et al. / Environmental Research 136 (2015) 67–7472(Redgrave et al., 2006). It is still unclear if, and how, cadmium
contributes to this process.
The key issue is smoking, since it is both a strong cardiovascular
risk factor and a very important source of cadmium exposure. Dataon life-long smoking exposure are based on self-reported in-
formation, whereas measurement of cotinine only informs on re-
cent smoking. In three of the studies in the meta-analysis men-
tioned above, adjustment was made concomitantly for smoking
status, pack-years of smoking, and cotinine, and the association
between cadmium exposure and cardiovascular disease remained
(Tellez–Plaza et al., 2013). Never smokers are of particular interest
and in the meta-analysis, the association between cadmium ex-
posure and cardiovascular disease did not reach statistical sig-
niﬁcance in never smoking groups, although the point estimate
(OR 1.27) suggested an effect. In the present study, we adjusted for
smoking status in terms of never, ex-, and current smoking or for
pack-years in a subgroup that did not include all subjects. In never
smoking subjects, there was no indication that increasing cad-
mium levels were associated with increased risk of atherosclerotic
plaques.
The effect of dietary exposure to cadmium has been examined
in two Swedish population-based studies of 33,000 women and
37,000 men (Julin et al., 2013a; Julin et al., 2013b). The validity of
this method of calculating cadmium intake from a food frequency
questionnaire has been investigated and is further supported by
the observations of signiﬁcant positive associations between this
measure of exposure from food and risk of fractures (Engström
et al., 2012; Thomas et al., 2011) and prostate (Julin et al., 2012a),
endometrial (Åkesson et al., 2008), and breast cancer (Julin et al.,
2012b) in these cohorts. However, in recent reports on the same
cohorts, no association was found between dietary cadmium in-
take and cardiovascular disease, although there were more than
8000 clinical events during 12 years of follow-up (Julin et al.,
2013a; Julin et al., 2013b). We suggest that this inconsistency can
be explained by two factors. Firstly, in the Swedish population, the
exposure to cadmium through diet is not high enough to have
discernable pro-atherogenic effects. Secondly, in never smokers,
dietary intake of cadmium, as well as biochemical markers such as
blood cadmium, are also measures of anti-atherogenic compo-
nents in the diet. Regarding the ﬁrst issue, it should be noted that
the cadmium concentrations in blood or urine indicate that ex-
posure is lower in Sweden (Fagerberg et al., 2012) than in many of
B. Fagerberg et al. / Environmental Research 136 (2015) 67–74 73the studies from the US (Peters et al., 2010; Agarwal et al., 2011;
Tellez–Plaza et al., 2010; Tellez–Plaza et al., 2012), Belgium (Na-
wrot et al., 2008), and Korea (Lee et al., 2011). In the present study,
we found that only 3.8% of the never smokers had a blood cad-
mium level corresponding to quartile 4, and the 95th percentile of
blood cadmium in never smokers was o0.5 μg/L. Our suggestion
is that cadmium exposure from diet below this level is not asso-
ciated with increased risk of carotid artery atherosclerosis. Further,
it is well known that high dietary intake of cadmium is largely
based on high intake of otherwise healthy food items, such as
whole grains and vegetables, and that non-smokers consume
more of these food items than ever-smokers (Nordberg et al.,
2007; Julin et al., 2013a; Julin et al., 2013b). Finally, it is well
documented in many studies that high intake of whole grains
reduces the risk of cardiovascular disease (Jacobs and Gallaher,
2004). As a supporting observation of this paradoxical health
promoting effect of cadmium containing food, we found that
among never smokers in the present study, blood cadmium con-
centrations showed beneﬁcial correlations with blood glucose
(r¼0.12, po0.0005), serum triglycerides (r¼0.07, po0.0005),
and HDL cholesterol (r¼0.14, po0.0005). However, in the ex-
andcurrent-smoking groups, we found no correlations to blood
glucose or HDL cholesterol (r¼-0.00 for both) and a positive cor-
relation to triglycerides (r¼0.07, po0.0005).
A limitation of the present study is that the information on
pack-years of smoking was incomplete, although it was available
for 3800 subjects. We did not have access to urinary cadmium
concentrations which are regarded as a better measure of long-
term exposure in ex-smokers. However, recent studies have raised
concerns about the usefulness of urine cadmium as a biomarker of
long-term cadmium exposure in populations exposed to low to
moderate cadmium levels (Akerstrom et al., 2013; Chaumont et al.,
2013).5. Conclusions
The conclusion is that our results extend previous studies of
cadmium exposure and cardiovascular events by adding data on
an association between cadmium and underlying atherosclerosis
in humans. In the subgroups-analyses the association between
blood cadmium and plaque prevalence was only found in smokers.
Smoking may both cause residual confounding and be a source of
pro-atherogenic cadmium exposure. This has to be further clar-
iﬁed. In the meantime, it is very important to minimize cadmium
exposure in the public, given the well-documented adverse effects
on health in many disease areas.Fundings
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